ArticleInternational journal of molecular sciences2026
Interleukin-2 and Tretinoin for Myeloproliferative Neoplasms and to Target Type 1 Calreticulin-Driven Neoplasms: Advancements in Immune Regenerative Medicine.
Dipnarine Maharaj et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.